BioCryst reports Q2 2026 results, completes navenibart pivotal enrollmentAug 5Quarterly updateberotralstatBiocryst Pharmaceuticals Inc
BioCryst to close Birmingham research site, ends internal discovery programsJun 29Clinical readoutBiocryst Pharmaceuticals Inc
Sign inSign in